t r a c t
Novelty seeking can be a positive trait leading to creativity and innovation, but it is also related to increased risk of damaging addictive behaviour. We have assessed novelty seeking with a three armed bandit task, in which novel stimuli were occasionally introduced, replacing choice options from which the participants had been choosing. This allowed us to assess whether or not they would be prone to selecting novel stimuli. We tested 25 non impulsive patients with Parkinson's disease (PD) and 27 PD patients with impulsive compulsive behaviours (ICBs). Both patient groups were examined "on" and "off" dopaminergic medication in a counterbalanced order and their behaviour was compared with 24 healthy controls. We found that PD patients with ICBs were significantly more prone to choose novel options than either non impulsive PD patients or controls, regardless of medication status. Our findings suggest that attraction to novelty is a personality trait in all PD patients with ICBs which is independent of medication status.
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Introduction
Humans and animals are inherently attracted to new stimuli as these can be potentially rewarding (Daffner et al., 1998; Ennaceur & Delacour, 1988; Hughes, 2007) . High novelty seeking is part of adolescence and may help in normal development and the acquisition of independence (Kelley et al., 2004) : adults with novelty seeking personality traits on the other hand often have increased impulsivity, addiction, inability to delay gratification, recklessness and aggressive behaviour (Barratt, 1985 (Barratt, , 1994 Belin et al., 2008) . A subgroup of patients with Parkinson's disease (PD) develop impulsive compulsive behaviours (PD + ICB) in relation to their dopamine replacement therapies. These include pathological gambling, compulsive sexual behaviour and shopping and the inappropriate, excessive overuse of dopaminergic medication (dopamine dysregulation syndrome, DDS) (Evans et al., 2005 (Evans et al., , 2006 Voon et al., 2007b) . While self-report questionnaires have suggested that the subgroup of PD + ICB patients with DDS (Evans et al., 2005) and those with pathological gambling (Voon et al., 2007b) have high levels of novelty seeking, this has not been formally studied using metric tests.
The trade-off between choosing options of known value and exploring novel options is known as exploration vs. exploitation (Daw et al., 2006) . Exploring novel choices and learning the value of stimuli based on reward feedback have been linked to the ventral striatum, the substantia nigra and the ventral tegmental area of the midbrain (Guitart-Masip et al., 2010; Wittmann et al., 2008) as well as the hippocampus (Guitart-Masip et al., 2010; Voon et al., 2010) . These areas either contain dopamine neurons or receive strong dopaminergic innervation. Additional studies have examined the dopamine link to learning and exploration. For example, behavioural studies in PD have shown that dopamine levels play an important role in reward learning (Cools et al., 2002; Djamshidian et al., 2010; Frank et al., 2004; Seo et al., 2010; Voon et al., 2010) . Complimenting this work, functional magnetic resonance imaging (fMRI) studies in healthy controls and positron emission tomography (PET) studies in PD + ICB patients have localized reward responsivity to the ventral striatum (Evans et al., 2010; O'Doherty et al., 2003; O'Sullivan et al., 2011; Steeves et al., 2009 ). An important role for striatal dopamine D2 receptors in the exploration vs. exploitation trade-off has been suggested by genetic studies (Frank et al., 2009) . It seems probable therefore that there is an overlap between the networks which mediate reward learning and novelty seeking, and both processes can be conceptualized as assigning value to choice options.
One of the circuits that has been proposed to mediate novelty effects includes the hippocampal projection to the ventral striatum. Specifically, the hippocampus forms a functional loop with
